Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
OSRX® logo — Compounded Ophthalmic Medications

OSRX®

Compounded Ophthalmic Medications

Founded 2019 United States Missoula, United States 49 employees

General Information

Company Name OSRX®
Founded Year 2019
Location United States Missoula, United States +1
Employees 49
Social

Get notified when OSRX® moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About OSRX®

OSRX® is a PCAB-accredited compounding pharmacy based in Missoula, Mont. The company specializes in compounding quality ophthalmic formulations. OSRX® focuses on customizing compounded medications to meet unique patient and practitioner needs. It's important to note that compounded drugs are not FDA-approved, meaning they have not undergone FDA premarket review for safety, effectiveness, and quality. OSRX® was founded in 2019 and is headquartered in the United States. As of now, there is no publicly available information regarding their last investment or the investors involved. Overall, OSRX® presents an intriguing value proposition with its focus on compounding ophthalmic medications. However, the lack of information regarding their last investment and investors could raise questions about their funding and growth trajectory. It will be crucial for potential investors to dive deeper into OSRX®'s financial history and current funding status before considering any investment opportunities. Additionally, given the regulatory considerations around compounded drugs, it will be essential for investors to assess the company's compliance and risk management strategies in relation to FDA regulations.

Taxonomy: Compounded medications, Ophthalmic formulations, Customized medications, PCAB-accredited pharmacy, Cataract post-op drops, Lasik post-op drops, Glaucoma management, Myopia management, Intracameral cataract injection, Optometry medication, Patient-specific formulations, Quality ophthalmic drugs, Compounding services, Ophthalmology services, Optometry services

No funding data available for OSRX® yet.

Get notified when OSRX® raises funding

FAQ About OSRX®

Compounded Ophthalmic Medications
OSRX® was founded in 2019.
OSRX® is headquartered in Missoula, United States.
OSRX® has approximately 49 employees.

We're actively collecting intelligence on OSRX®.

Track OSRX® to get notified

Don't just browse. Track.

Signal Tracker monitors OSRX® and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy